New chat

Home
Prompt library
NEW
AI alerts
Watchlists
Projects
Filings & transcripts
Your files
Feed
Connectors
Personalization

You're signed outSign in or to get full access.

Research
MLTX
Earnings

MI

MoonLake Immunotherapeutics (MLTX)·Earnings Reports

MoonLake Immunotherapeutics Q4 2025 earnings results — positive Phase 2 axSpA data, cash runway extended

Q4 2025

View earnings summary and analysis

Q3 2025

View earnings summary and analysis

Q2 2025

View earnings summary and analysis

Q1 2025

View earnings summary and analysis

Q4 2024

View earnings summary and analysis

Analyst Coverage

Research analysts covering MoonLake Immunotherapeutics.

Recent News about MoonLake Immunotherapeutics

MoonLake's Investor Day Delivers 81% Response Rate in Spine Disease—Best Ever in Clinical Trial

MoonLake's Investor Day Delivers 81% Response Rate in Spine Disease—Best Ever in Clinical Trial